International CML Foundation
The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally.
Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.
As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure.
Join us and contribute to a world where a cure for CML is not just a hope, but a reality.
iCMLf Prize Presentation 2025
Janet Rowley Prize Presentation 2025
John Goldman Prize Presentation 2025
iCMLf Prize Keynote 2025 N.A. Othino-Abinya
Janet Rowley Prize Keynote 2025: Satu Musjoki
John Goldman Prize Keynote 2025 Dr Delphine Rea
La LMC comme tumeur maligne secondaire
CML as a Secondary Malignancy
Prise en charge de la LMC en phase avancée dans les pays à ressources limitées – Tanzanie
Management of Advanced Phase CML in Resource-Limited Settings - Tanzania
Clinical Highlights of of ESH-iCMLf 27th Annual John Goldman Conference 2025
Leucémie myéloïde chronique et grossesse dans les contextes aux ressources limitées
CML and Pregnancy in Resource-Constrained Settings
Surmonter les difficultés d'adhésion au traitement thérapeutique
Overcoming Challenges in Adherence to Therapy
ESH-iCMLf 27th Annual John Goldman Conference on CML: Biology and Therapy
iCMLF, A Review: Chairman Jorge Cortes
Surveillance et intervention BCR ABL : Répondeurs lents – Directives actuelles
BCR ABL Monitoring and Intervention: Slow Responders - Current Guidance
Attempting TFR in Resource-Constrained Settings
Tenter l'approche TFR dans des contextes aux ressources limitées
Sanger vs. NGS para el análisis de mutaciones: aplicabilidad en la realidad latinoamericana
Sanger vs NGS for Mutation Analysis: Applicability in Real-World Latin America
Monitoreo molecular y análisis de mutaciones para el manejo de la LMC en Latinoamérica
Molecular Monitoring & Mutation Analysis to be considered for CML Management in Latin America
The Breakthrough That Changed Cancer Forever
CML Highlights of EHA 2025 - Clinical Overview incl. Q&A Session
CML Highlights of EHA 2025 - Biological Overview
2025 ELN Recommendations on the Management of CML